Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Lucifora

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|April 17, 2016
Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cureJulie Lucifora, Ulrike Protzer
Antiviral Research|May 4, 2020
Current knowledge on Hepatitis Delta Virus replicationJulie Lucifora, Marion Delphin
Nature Reviews. Gastroenterology & Hepatology|June 24, 2015
Hepatitis: After HCV cure, HBV cure?Julie Lucifora, Christian Trepo
Plos Pathogens|May 12, 2025
TRIM proteins: A 'swiss army knife' of antiviral immunityElise Chabot, David Durantel, Julie Lucifora
Antiviral Research|December 26, 2012
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytesJulie Lucifora, Knud Esser, Ulrike Protzer
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2018
Liver macrophages: Friend or foe during hepatitis B infection?Suzanne Faure-Dupuy, David Durantel, Julie Lucifora
Viruses|April 29, 2017
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic ConceptsSuzanne Faure-Dupuy, Julie Lucifora, David Durantel
Trends in Pharmacological Sciences|August 11, 2014
New pharmacological strategies to fight enveloped virusesKarin Wisskirchen, Julie Lucifora, Thomas Michler, et al.
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Cells|October 17, 2020
Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus InfectionsJulie Lucifora, Maud Michelet, Anna Salvetti, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|April 17, 2016
Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cureJulie Lucifora, Ulrike Protzer
Antiviral Research|May 4, 2020
Current knowledge on Hepatitis Delta Virus replicationJulie Lucifora, Marion Delphin
Nature Reviews. Gastroenterology & Hepatology|June 24, 2015
Hepatitis: After HCV cure, HBV cure?Julie Lucifora, Christian Trepo
Plos Pathogens|May 12, 2025
TRIM proteins: A 'swiss army knife' of antiviral immunityElise Chabot, David Durantel, Julie Lucifora
Antiviral Research|December 26, 2012
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytesJulie Lucifora, Knud Esser, Ulrike Protzer
Liver International : Official Journal of the International Association for the Study of the Liver|May 18, 2018
Liver macrophages: Friend or foe during hepatitis B infection?Suzanne Faure-Dupuy, David Durantel, Julie Lucifora
Viruses|April 29, 2017
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic ConceptsSuzanne Faure-Dupuy, Julie Lucifora, David Durantel
Trends in Pharmacological Sciences|August 11, 2014
New pharmacological strategies to fight enveloped virusesKarin Wisskirchen, Julie Lucifora, Thomas Michler, et al.
Antiviral Research|August 16, 2015
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategiesNathalie Isorce, Julie Lucifora, Fabien Zoulim, et al.
Cells|October 17, 2020
Fast Differentiation of HepaRG Cells Allowing Hepatitis B and Delta Virus InfectionsJulie Lucifora, Maud Michelet, Anna Salvetti, et al.
Pageof 7